UNSPSC 51291505: Cyclazodone

This classification denotes a cns stimulant with the molecular formula C12H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O8U55ZRL9K, chemically known as 4(5h)-oxazolone, 2-(cyclopropylamino)-5-phenyl- (9ci) but generally known as cyclazodone, which bears US NIH Compound Identifier 26701. European Medicines Agency schedules Cyclazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06844MIG.

UNSPSC 51291505 Cyclazodone is a Commodity code that captures pharmaceutical and medical countermeasure procurement by state and local health authorities. Recent solicitation activity under this code shows state and local governments buying naloxone and drug deactivation systems to support community health and overdose-response initiatives. The issuing bodies are county health departments and public health agencies pursuing competitive bids for supply contracts with fixed delivery schedules and performance requirements including insurance coverage, E-Verify compliance, and drug-free workplace certification.

Seminole County, Florida posted an IFB (Invitation for Bid) in mid-2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The contract carries a two-year initial term with one-year renewal option, potential FEMA funding, and federal compliance requirements. The source provides limited geographic scope; activity is confined to the single Seminole County opportunity with no additional state or local jurisdictions represented in the recent-opportunities record.